FI882819A0 - Analogiamenetelmä medetomidiinin terapeuttisesti aktiivisen d-isomeerin valmistamiseksi - Google Patents

Analogiamenetelmä medetomidiinin terapeuttisesti aktiivisen d-isomeerin valmistamiseksi

Info

Publication number: FI882819A0
Authority: FI; Finland
Prior art keywords: medetomidine; isomer; preparation; therapeutically active; analogous method
Prior art date: 1987-07-16

Application number

FI882819A

Other languages

English (en)

Swedish (sv)

Other versions

FI95375B (fi

FI95375C (fi

FI882819L (fi

Inventor

Arto Johannes Karjalainen

Raimo Einari Virtanen

Eino Juhani Savolainen

Original Assignee

Farmos Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-16

Filing date

1988-06-14

Publication date

1988-06-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10620775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI882819(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-06-14 Application filed by Farmos Oy filed Critical Farmos Oy

1988-06-14 Publication of FI882819A0 publication Critical patent/FI882819A0/fi

1989-01-17 Publication of FI882819L publication Critical patent/FI882819L/fi

1995-10-13 Publication of FI95375B publication Critical patent/FI95375B/fi

1996-01-25 Application granted granted Critical

1996-01-25 Publication of FI95375C publication Critical patent/FI95375C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Optical Record Carriers And Manufacture Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Photoreceptors In Electrophotography (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FI882819A 1987-07-16 1988-06-14 Analogiamenetelmä medetomidiinin terapeuttisesti aktiivisen d-isomeerin valmistamiseksi FI95375C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8716803		1987-07-16
GB8716803A GB2206880B (en)	1987-07-16	1987-07-16	Optical isomers of an imidazole derivative

Publications (4)

Publication Number	Publication Date
FI882819A0 true FI882819A0 (fi)	1988-06-14
FI882819L FI882819L (fi)	1989-01-17
FI95375B FI95375B (fi)	1995-10-13
FI95375C FI95375C (fi)	1996-01-25

Family

ID=10620775

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI882819A FI95375C (fi)	1987-07-16	1988-06-14	Analogiamenetelmä medetomidiinin terapeuttisesti aktiivisen d-isomeerin valmistamiseksi

Country Status (29)

Country	Link
US (1)	US4910214A (fi)
EP (1)	EP0300652B1 (fi)
JP (1)	JPH0625138B2 (fi)
KR (1)	KR940007311B1 (fi)
CN (1)	CN1022323C (fi)
AT (1)	ATE71941T1 (fi)
AU (1)	AU600839B2 (fi)
BG (1)	BG60473B2 (fi)
CA (1)	CA1337659C (fi)
CY (2)	CY1787A (fi)
DD (1)	DD281807A5 (fi)
DE (2)	DE3867945D1 (fi)
DK (1)	DK165788C (fi)
ES (1)	ES2038757T3 (fi)
FI (1)	FI95375C (fi)
GB (1)	GB2206880B (fi)
GR (1)	GR3003878T3 (fi)
HK (1)	HK56094A (fi)
HU (1)	HU198693B (fi)
IE (1)	IE60456B1 (fi)
IL (1)	IL87076A0 (fi)
LU (1)	LU91010I2 (fi)
NL (1)	NL300117I2 (fi)
NO (2)	NO170579C (fi)
NZ (1)	NZ225362A (fi)
PT (1)	PT88013B (fi)
SU (1)	SU1648248A3 (fi)
UA (1)	UA5560A1 (fi)
ZA (1)	ZA885134B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2215206B (en) *	1988-02-29	1991-07-03	Farmos Oy	4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) *	1989-08-18	1992-06-23	Cygnus Therapeutic Systems	Method and device for administering dexmedetomidine transdermally
US5120713A (en) *	1990-09-10	1992-06-09	Applied Research Systems Ars Holding N.V.	Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
GB9111732D0 (en) *	1991-05-31	1991-07-24	Orion Yhtymae Oy	The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2281206A (en) *	1993-08-25	1995-03-01	Orion Yhtymae Oy	Use of dexmedetomidine
GB9425211D0 (en) *	1994-12-14	1995-02-15	Ucb Sa	Substituted 1H-imidazoles
IN187238B (fi) *	1995-06-30	2002-03-09	Astra Ab
GB9521680D0 (en) *	1995-10-23	1996-01-03	Orion Yhtymo Oy	New use of imidazole derivatives
US5866579A (en) *	1997-04-11	1999-02-02	Synaptic Pharmaceutical Corporation	Imidazole and imidazoline derivatives and uses thereof
AR015744A1 (es) *	1998-04-01	2001-05-16	Orion Corp	Uso de dexmedetomidina para sedacion en terapia intensiva
US6716867B1 (en)	1998-04-01	2004-04-06	Orion Corporation	Use of dexmedetomidine for ICU sedation
NZ518447A (en)	1999-10-29	2004-10-29	Orion Corp	Treatment or prevention of hypotension and shock
US6388090B2 (en) *	2000-01-14	2002-05-14	Orion Corporation	Imidazole derivatives
US7141597B2 (en) *	2003-09-12	2006-11-28	Allergan, Inc.	Nonsedating α-2 agonists
EP2218442A1 (en)	2005-11-09	2010-08-18	CombinatoRx, Inc.	Methods, compositions, and kits for the treatment of ophthalmic disorders
ATE536867T1 (de)	2006-03-16	2011-12-15	Tris Pharma Inc	Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US7795263B2 (en) *	2008-07-08	2010-09-14	Wildlife Laboratories, Inc.	Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20100196286A1 (en) *	2008-12-01	2010-08-05	Armer Thomas A	Inhalation delivery methods and devices
US8555875B2 (en) *	2008-12-23	2013-10-15	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
KR101859486B1 (ko) *	2009-05-15	2018-06-28	레크로파마, 인코포레이티드	설하용 덱스메데토미딘 조성물과 그의 사용 방법
CN101671305A (zh) *	2009-09-29	2010-03-17	北京华禧联合科技发展有限公司	一种拆分美托咪定的左旋及右旋对映体的方法
CN102464619A (zh) *	2010-11-17	2012-05-23	桑迪亚医药技术（上海）有限责任公司	一种左旋4-[1-(2,3-二甲基苯基)乙基]-1r-咪唑消旋化方法
US20130096170A1 (en)	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en)	2011-11-11	2013-05-16	Neon Laboratories Ltd.	"process for the preparation of dexmedetomidine"
SG11201403094TA (en)	2011-12-11	2014-10-30	Recro Pharma Inc	Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en)	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
ITMI20120311A1 (it) *	2012-02-29	2013-08-30	Edmond Pharma Srl	Procedimento per la risoluzione di medetomidina e recupero dell'enantiomero indesiderato
BR112015003120B1 (pt)	2012-08-15	2022-08-09	Tris Pharma , Inc	Tablete mastigável de liberação estendida de metilfenidato e seu uso
HUE037272T2 (hu) *	2012-10-15	2018-08-28	Orion Corp	Állatorvosi módszer zajérzékenység enyhítésére
RU2646512C2 (ru)	2013-10-07	2018-03-05	ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК.	Устройства для трансдермальной доставки дексмедетомидина и способы их применения
RU2648449C2 (ru)	2013-10-07	2018-03-26	ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК.	Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
KR101831290B1 (ko)	2013-10-07	2018-02-22	테이코쿠 팔마 유에스에이, 인코포레이티드	덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
CN105175339B (zh) *	2015-10-09	2018-01-16	辰欣药业股份有限公司	一种制备盐酸右美托咪定的方法
US9717796B1 (en)	2016-04-20	2017-08-01	Slypharma, Llc	Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
FR3054218B1 (fr) *	2016-07-22	2020-03-06	Universite De Rouen	Procede de dedoublement de sels de baclofene
RU2723761C1 (ru)	2016-10-31	2020-06-17	ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК.	Способы устранения боли с использованием устройств для трансдермальной доставки дексмедетомидина
US11160791B2 (en)	2018-11-01	2021-11-02	Medefil, Inc.	Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CN115197149B (zh) *	2021-04-02	2023-09-22	四川大学华西医院	一种5-苄基咪唑类化合物及其制备方法和用途
CN114671811A (zh) *	2022-04-14	2022-06-28	南京正科医药股份有限公司	一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU518569B2 (en) *	1979-08-07	1981-10-08	Farmos-Yhtyma Oy	4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) *	1981-02-05	1984-09-19	Farmos Oy	Substituted imidazole derivatives and their preparation and use
GB2101114B (en)	1981-07-10	1985-05-22	Farmos Group Ltd	Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi)	1984-12-04	1984-12-04	Farmos Oy	Terapeutiskt utnyttjbar foerening.
DE3531682A1 (de) *	1985-09-05	1987-03-12	Thomae Gmbh Dr K	(+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel

1987
- 1987-07-16 GB GB8716803A patent/GB2206880B/en not_active Expired - Lifetime
1988
- 1988-06-14 FI FI882819A patent/FI95375C/fi active Protection Beyond IP Right Term
- 1988-06-28 UA UA4356076A patent/UA5560A1/uk unknown
- 1988-06-28 SU SU884356076A patent/SU1648248A3/ru active
- 1988-07-08 DE DE8888306250T patent/DE3867945D1/de not_active Expired - Lifetime
- 1988-07-08 AT AT88306250T patent/ATE71941T1/de active
- 1988-07-08 DE DE2003199005 patent/DE10399005I2/de active Active
- 1988-07-08 ES ES198888306250T patent/ES2038757T3/es not_active Expired - Lifetime
- 1988-07-08 EP EP88306250A patent/EP0300652B1/en not_active Expired - Lifetime
- 1988-07-11 NZ NZ225362A patent/NZ225362A/xx unknown
- 1988-07-11 AU AU18941/88A patent/AU600839B2/en not_active Expired
- 1988-07-11 DK DK386288A patent/DK165788C/da not_active IP Right Cessation
- 1988-07-12 IL IL87076A patent/IL87076A0/xx not_active IP Right Cessation
- 1988-07-14 CA CA000572086A patent/CA1337659C/en not_active Expired - Lifetime
- 1988-07-14 DD DD88317936A patent/DD281807A5/de not_active IP Right Cessation
- 1988-07-15 ZA ZA885134A patent/ZA885134B/xx unknown
- 1988-07-15 NO NO883155A patent/NO170579C/no not_active IP Right Cessation
- 1988-07-15 PT PT88013A patent/PT88013B/pt not_active IP Right Cessation
- 1988-07-15 KR KR1019880008937A patent/KR940007311B1/ko not_active Expired - Lifetime
- 1988-07-15 US US07/219,637 patent/US4910214A/en not_active Expired - Lifetime
- 1988-07-15 IE IE217488A patent/IE60456B1/en not_active IP Right Cessation
- 1988-07-15 HU HU883708A patent/HU198693B/hu unknown
- 1988-07-16 JP JP63177959A patent/JPH0625138B2/ja not_active Expired - Lifetime
- 1988-07-16 CN CN88104440A patent/CN1022323C/zh not_active Expired - Lifetime
1992
- 1992-02-21 GR GR920400299T patent/GR3003878T3/el unknown
1994
- 1994-01-18 BG BG098380A patent/BG60473B2/bg unknown
- 1994-05-24 HK HK56094A patent/HK56094A/en not_active IP Right Cessation
1995
- 1995-10-20 CY CY178795A patent/CY1787A/xx unknown
2003
- 2003-02-14 LU LU91010C patent/LU91010I2/fr unknown
- 2003-03-03 NL NL300117C patent/NL300117I2/nl unknown
- 2003-07-01 NO NO2003004C patent/NO2003004I2/no unknown
2004
- 2004-10-27 CY CY200400006C patent/CY2004006I1/el unknown

Also Published As

Publication number	Publication date
ES2038757T3 (es)	1993-08-01
IE60456B1 (en)	1994-07-13
KR890002030A (ko)	1989-04-07
FI95375B (fi)	1995-10-13
HU198693B (en)	1989-11-28
DE10399005I2 (de)	2012-06-06
AU600839B2 (en)	1990-08-23
AU1894188A (en)	1989-01-19
GB2206880A (en)	1989-01-18
FI95375C (fi)	1996-01-25
EP0300652B1 (en)	1992-01-22
DD281807A5 (de)	1990-08-22
DE10399005I1 (de)	2003-06-05
FI882819L (fi)	1989-01-17
ZA885134B (en)	1989-04-26
JPH0625138B2 (ja)	1994-04-06
SU1648248A3 (ru)	1991-05-07
CA1337659C (en)	1995-11-28
CY1787A (en)	1995-10-20
NO883155L (no)	1989-01-17
NZ225362A (en)	1990-07-26
CN1030576A (zh)	1989-01-25
GR3003878T3 (fi)	1993-03-16
NL300117I1 (nl)	2003-05-01
US4910214A (en)	1990-03-20
JPS6434968A (en)	1989-02-06
UA5560A1 (uk)	1994-12-28
NO2003004I2 (no)	2005-03-21
DE3867945D1 (de)	1992-03-05
DK386288D0 (da)	1988-07-11
IL87076A0 (en)	1988-12-30
HUT48218A (en)	1989-05-29
DK386288A (da)	1989-01-17
KR940007311B1 (ko)	1994-08-12
CN1022323C (zh)	1993-10-06
EP0300652A1 (en)	1989-01-25
NO170579B (no)	1992-07-27
NL300117I2 (nl)	2003-10-01
GB2206880B (en)	1991-04-24
DK165788B (da)	1993-01-18
GB8716803D0 (en)	1987-08-19
PT88013B (pt)	1995-03-01
CY2004006I2 (el)	2009-11-04
CY2004006I1 (el)	2009-11-04
BG60473B2 (bg)	1995-04-28
IE882174L (en)	1989-01-16
LU91010I2 (fr)	2003-06-19
ATE71941T1 (de)	1992-02-15
DK165788C (da)	1993-06-14
PT88013A (pt)	1989-06-30
NO883155D0 (no)	1988-07-15
NO170579C (no)	1992-11-04
HK56094A (en)	1994-06-03

Publication	Publication Date	Title
FI882819A0 (fi)	1988-06-14	Analogiamenetelmä medetomidiinin terapeuttisesti aktiivisen d-isomeerin valmistamiseksi
FI883050L (fi)	1988-12-25	Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI880816A7 (fi)	1988-09-24	Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
FI893170L (fi)	1989-12-29	Menetelmä uusien terapeuttisesti käyttökelpoisten 1,2,3-triatsolo/4,5-f/kinoksaliinijohdannaisten valmistamiseksi
FI875666L (fi)	1988-06-24	Menetelmä terapeuttisesti aktiivisen kinoliiniyhdisteen valmistamiseksi
FI861547A7 (fi)	1986-10-16	Menetelmä antibakteerisesti vaikuttavien kinoliini-3-karboksyylihappojen valmistamiseksi.
FI884627A7 (fi)	1989-04-10	Menetelmä uusien terapeuttisesti käyttökelpoisten dideoksisytidiinijohdannaisten valmistamiseksi
NO864733D0 (no)	1986-11-26	Apparat for elektrokjemisk bearbeidelse av et arbeidsstykke.
FI884660L (fi)	1989-04-13	Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
BG40650A3 (en)	1986-01-15	Method for preparing ester of treo- 2- hydroxy- 3- (4- metoxyphenyl)- 3- (2- nitrophenylthio)- propionic acid
FI880190L (fi)	1988-07-28	Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia
AU591120B2 (en)	1989-11-30	Treatment of psychostimulant addiction using a dopamine agonist
FI863471A7 (fi)	1987-03-01	Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
FI883248A7 (fi)	1989-01-11	Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi
IT1190526B (it)	1988-02-16	Apparecchio perfezionato per la sfogliatura di piccoli tronchi d'albero per la produzione di impiallacciatura
DE3689764D1 (de)	1994-05-11	Zwischenprodukte und Verfahren zu ihrer Herstellung.
DE3661312D1 (de)	1989-01-05	Process for preparing an aziridine derivative
BG44022A3 (en)	1988-09-15	Method for preparing of ester derivatives of diphenylether oximes
FI906409A7 (fi)	1990-12-27	Menetelmä terapeuttisesti aktiivisten aryylisyklobutyylialkyyliamiinijohdannaisten valmistamiseksi
IT8519972A0 (it)	1985-03-20	Testata autocentrante per il supporto rotante di alberi esimili.
GR1000201B (el)	1992-03-20	Mέ?οδος για την παρασκευή του 1-κυκλοπροπυλο-6-φ?ορο-1,4-διϋδρο-4-οξο-7κινολίνο-3-καρβοξυλικού οξέος δομικού λί?ου παρασκευής των 1-κυκλοπρόπυλο-6-φ?όρο-1,4-διϋδρο-4οξο-7-πιπεράζινο-κινολινο 3καρβοξυλικών οξέων.
KR870009752U (ko)	1987-07-08	레이저 가공기의 가공 헤드 조절 장치

Legal Events

Date	Code	Title	Description
1988-06-14	FG	Patent granted	Owner name: ORION-YHTYMAE OY
1995-09-18	BB	Publication of examined application
1996-01-19	GB	Transfer or assigment of application	Owner name: ORION-YHTYMAE OY
2003-02-25	SPCF	Supplementary protection certificate application filed	Spc suppl protection certif: L20030004
2004-08-31	FG	Patent granted	Owner name: ORION-YHTYMAE OY
2006-11-20	SPCG	Supplementary protection certificate granted	Spc suppl protection certif: L196 Extension date: 20130613